4//SEC Filing
Nouri Alaleh 4
Accession 0001628280-24-050221
CIK 0001588978other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:17 PM ET
Size
20.0 KB
Accession
0001628280-24-050221
Insider Transaction Report
Form 4
Nouri Alaleh
EVP, CLO, CORP. SEC.
Transactions
- Exercise/Conversion
Common Stock
2024-12-04$34.99/sh+4,162$145,628→ 68,472 total - Sale
Common Stock
2024-12-04$96.12/sh−3,787$364,006→ 76,777 total - Sale
Common Stock
2024-12-04$96.98/sh−16,187$1,569,815→ 60,590 total - Sale
Common Stock
2024-12-04$97.90/sh−8,118$794,752→ 52,472 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-04−12,092→ 26,094 totalExercise: $37.02Exp: 2033-02-15→ Common Stock (12,092 underlying) - Exercise/Conversion
Common Stock
2024-12-04$7.27/sh+11,838$86,062→ 64,310 total - Exercise/Conversion
Common Stock
2024-12-04$37.02/sh+12,092$447,646→ 80,564 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-04−11,838→ 21,056 totalExercise: $7.27Exp: 2031-06-21→ Common Stock (11,838 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-04−4,162→ 2,728 totalExercise: $34.99Exp: 2032-03-30→ Common Stock (4,162 underlying)
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The Stock option was granted on June 22, 2021 and vested over a four year period.
- [F6]The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.
- [F7]The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
Documents
Issuer
PROCEPT BioRobotics Corp
CIK 0001588978
Entity typeother
Related Parties
1- filerCIK 0001599418
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:17 PM ET
- Size
- 20.0 KB